沙特阿拉伯偏头痛管理:专家共识
该专家共识基于最新国际指南和当地临床实践,针对沙特阿拉伯偏头痛的预防治疗达成共识,重点涉及CGRP单克隆抗体的使用;共识涵盖治疗启动标准、患者选择及CGRP单克隆抗体在临床实践中的作用,强调早期启动有效治疗以减轻疾病负担并改善生活质量。
要点
- 专家组共识推荐CGRP单克隆抗体作为偏头痛预防治疗的一线选择。
- 共识强调需要更早启动有效治疗以减轻疾病负担并改善生活质量。
- 共识涵盖治疗启动标准、患者选择及CGRP单克隆抗体在临床实践中的作用。
核心结论
- 该专家共识为沙特阿拉伯偏头痛的预防治疗提供了更新指导,支持将CGRP单克隆抗体整合为一线选择,旨在提升偏头痛诊疗标准并解决当地医疗环境中未满足的需求。
研究设计与样本
- 专家共识;专家组回顾了更新的临床数据和近期推荐CGRP单克隆抗体作为一线预防治疗选择的国际指南。
诊断标准与关键数值
- 专家组共识推荐CGRP单克隆抗体作为一线预防治疗选择。
- 共识涵盖治疗启动标准、患者选择及CGRP单克隆抗体在临床实践中的作用。
临床应用与阅片要点
- 共识推荐将CGRP单克隆抗体作为偏头痛预防治疗的一线选择。
- 共识强调需要更早启动有效治疗以减轻疾病负担并改善生活质量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To establish expert consensus on the preventive treatment of migraine in Saudi Arabia, with a focus on the use of calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs), in light of the latest international guidelines and local clinical practice.
METHOD: A record-based study was performed retrospectively in Radiology department at our Hospital in Eastern region of Saudi Arabia, from Jan. 2019-2024. Adult patients for whom MRI brains were conducted for epilepsy work-up with added SWAN (susceptibility weighted angiography) sasequence were considered. Brain tumor, post-injury, and post-surgery cases were excluded. A venous angioma was documented when a tuft of veins drained to a larger vein (traversing through cortex or reaching under ependymal layer), appeared low signal curvilinear brnaching structure on SWAN image. The usefulness of the SWAN sequence in the detection of venous malformation determined if the visualized abnormality was found to be related to a focus resulting in abnormal waves on the brain electroencephalography. This observation was compared to the accidently found such malformations that were seen in epileptic patients with normal EEGs (control group). Fisher's Exact test was applied and a p-value of <0.05 was taken as statistically significant for an association.
RESULTS: The expert panel reviewed updated clinical data and recent international guidelines recommending CGRP mAbs as first-line preventive treatment options. The panel reached consensus on key aspects of migraine management in Saudi Arabia, including treatment initiation criteria, patient selection, and the role of CGRP mAbs in clinical practice. The recommendations emphasize the need for earlier initiation of effective treatments to reduce disease burden and improve quality of life.
CONCLUSION: This expert consensus provides updated guidance on the preventive treatment of migraine in Saudi Arabia, supporting the integration of CGRP mAbs as a first-line option. These recommendations aim to enhance the standard of migraine care and address unmet needs in the local healthcare setting.
引用
- Albilali AS, Alkawi AM, Alotaibi ND, et al. Migraine management in Saudi Arabia: An expert consensus. Neurosciences (Riyadh). 2025. PMID: 40670062. doi:10.17712/nsj.2025.3.20240118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。